
What is Autologous NK Cell Therapy?
Natural killer (NK) cells are a type of white blood cell and a front-line component of the body's innate immune system. Unlike many other immune cells, NK cells can recognize and respond to stressed, abnormal, or virally affected cells without needing prior sensitization.
In autologous NK cell therapy, a sample of your own blood is collected, and the NK cells are separated, expanded in number, and activated under controlled laboratory conditions before being returned to you. Because the cells originate from your own body, the risk of immune rejection is minimized.
StemCell Longevita operates as an international patient coordination platform. We connect you with a GMP-certified laboratory and an experienced clinical team so that any decision about suitability, dosing, and administration is made by qualified physicians after a full medical review.
The Science Behind the Approach
Innate Immune Surveillance
NK cells continuously survey the body for cells displaying abnormal surface signals and can act quickly as part of the innate immune response.
Laboratory Expansion & Activation
Collected NK cells are cultured to increase their number and activation state under GMP-controlled conditions before reinfusion.
Autologous (Self) Source
Because the cells are derived from your own blood, compatibility concerns associated with donor material are reduced.
Physician-Directed Administration
Reinfusion is performed in a clinical setting under medical supervision, typically as an intravenous infusion following individual assessment.
Potential Candidates
Before You Proceed
How the Process Works
Consultation & Medical Review
You share your medical history and records. A specialist assesses whether autologous NK cell therapy may be appropriate for your situation.
Cell Collection
A blood sample is collected so that your NK cells can be isolated for laboratory processing.
GMP Laboratory Processing
Your NK cells are expanded and activated under controlled, GMP-certified conditions with quality and viability checks.
Reinfusion & Follow-Up
The prepared cells are returned to you under medical supervision, followed by a structured follow-up plan.
Pricing & Personalized Quotes
Advanced cell therapies are highly individualized. Pricing depends on the protocol confirmed by the clinical team after your evaluation, so a personalized quote is provided during your consultation rather than a fixed list price.
Frequently Asked Questions
What is the difference between autologous and allogeneic NK cell therapy?
Autologous therapy uses your own NK cells, while allogeneic therapy uses NK cells from a screened donor. The most suitable option is determined by the clinical team based on your individual assessment.
Is autologous NK cell therapy safe?
Because the cells come from your own body, the risk of immune rejection is minimized. All procedures are carried out in a GMP-certified laboratory and administered under medical supervision. As with any medical intervention, potential risks are discussed during your consultation.
How long does the process take?
The timeline includes an initial consultation, blood collection, a laboratory expansion period, and reinfusion. Your coordinator will provide an estimated schedule after your medical review.
Can NK cell therapy replace my current treatment?
No. Advanced cell therapies are intended to complement, not replace, care recommended by your own physician. Always discuss any new therapy with your treating doctor.
